View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

RGC Resources, Inc. Schedules First Quarter 2026 Earnings Call

RGC Resources, Inc. Schedules First Quarter 2026 Earnings Call ROANOKE, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal first quarter 2026 on Tuesday, February 10, 2026 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at . Interested parties may access the conference call by dialing toll-free 1-877-304-9269 and entering conference identification number 917621. An arc...

 PRESS RELEASE

Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors -- Veteran Executive Brings More Than 25 Years of Clinical Development and Industry Expertise -- BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the appointment of Samit Hirawat, M.D., to its Board of Directors. This appointment increases the size of the company’s Board of Directors to 10 members. “Samit is an accomplished and widely re...

 PRESS RELEASE

CPS Announces $345.61 Million Senior Subordinate Asset-Backed Securiti...

CPS Announces $345.61 Million Senior Subordinate Asset-Backed Securitization LAS VEGAS, Nevada, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) announced the closing of its first term securitization in 2026 on Tuesday January 27, 2026. The transaction is CPS's 58th senior subordinate securitization since the beginning of 2011 and the 41st consecutive securitization to receive a triple “A” rating from at least two rating agencies on the senior class of notes. In the transaction, qualified institutional buyers purchased $345.61 mi...

 PRESS RELEASE

RGC Resources Holds Annual Shareholders Meeting

RGC Resources Holds Annual Shareholders Meeting ROANOKE, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (NASDAQ: RGCO) announced the election of Directors at its shareholders meeting held on January 26, 2026. Shareholders elected Jacqueline L. Archer, Frank Russell Ellett and Robert B. Johnston for three-year terms. Shareholders also ratified the appointment of Deloitte & Touche, LLP as auditors for fiscal 2026. At a meeting of the Board of Directors, following the annual shareholders meeting, John B. Williamson III was elected Chairman of the Board and Paul W. Nester was el...

 PRESS RELEASE

Northern Technologies International Corporation Announces Quarterly Ca...

Northern Technologies International Corporation Announces Quarterly Cash Dividend MINNEAPOLIS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today announced that the Board of Directors declared a quarterly cash dividend of $0.01 per share payable on February 11, 2026, to shareholders of record at the close of business on January 28, 2026.   About Northern Technologies International CorporationNorthern Techno...

 PRESS RELEASE

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in ...

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets -- LG Chem becomes exclusive distributor of EXPAREL --  – Partnership expands patient access to opioid-sparing pain control and advances 5x30 strategy– BRISBANE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced it has entered into an agreement with LG Chem designed to expand access to opioid-sparing postsurgical pain c...

 PRESS RELEASE

CPS Announces New $900 Million Forward Flow Agreement

CPS Announces New $900 Million Forward Flow Agreement LAS VEGAS, Nevada, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that on December 12, 2025, it began a new forward flow program with Valley Strong Credit Union, a leading full-service credit union located in California’s Central Valley. Valley Strong’s commitment under the forward flow program will enable CPS to expand its annual origination volumes by as much as $900 million. The program will focus on borrowers with prime credit, providing CPS the opportuni...

 PRESS RELEASE

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025...

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues -- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported preliminary, unaudited total revenue of $726.4 million for the year ended December 31, 2025, compared with $701.0 million for the year ended December 31, ...

 PRESS RELEASE

Northern Technologies International Corporation Reports Financial Resu...

Northern Technologies International Corporation Reports Financial Results for First Quarter Fiscal 2026 MINNEAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the first quarter of fiscal 2026. First quarter fiscal 2026 financial and operating highlights include (with growth rates on a fiscal quarter year-over-year basis): Consolidated net sales increased 9.2% to ...

 PRESS RELEASE

Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcar...

Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday, January 14, 2026. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at . A replay of the webcast will also be availa...

 PRESS RELEASE

Northern Technologies International Corporation to Announce Fiscal 202...

Northern Technologies International Corporation to Announce Fiscal 2026 First-Quarter Financial Results and Host Conference Call MINNEAPOLIS, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC) today announced that it expects to release its fiscal 2026 first-quarter financial results on Thursday, January 8, 2026, before the market opens. A copy of the news release will be available on the Investor Relations section of NTIC’s webpage (). In conjunction with NTIC’s release of its financial and operating results, investors, analysts, and other in...

 PRESS RELEASE

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis ...

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care --Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment----PROBE will leverage data from over 70 million individuals across multiple OA cohorts and real-world registries-- BRISBANE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Pacira Biosciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced it has joined the PROBE (Patient Relevant Osteoarthritis endpoints using B...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 13, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Consumer Portfolio Services Inc: 1 director

A director at Consumer Portfolio Services Inc sold 100,000 shares at 8.690USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule...

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on December 1, 2025 to two new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), ...

 PRESS RELEASE

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonst...

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain -- New data published in Pain Physician shows significant improvement in functional outcomes with iovera° ---- Fewer iovera° patients required additional spine injections after 180 days ---- No treatment-related adverse events were reported -- BRISBANE, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver inn...

 PRESS RELEASE

Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against...

Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical -- Lawsuit triggers 30-month stay under the Hatch Waxman Act -- BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has filed a patent infringement lawsuit in the United States District Court for the District of Delaware against The WhiteOak Group, Inc. and Qilu Pharmaceutical (Hainan) Co., ...

 PRESS RELEASE

RGC Resources, Inc. Raises Annual Dividend to $0.87 Per Share

RGC Resources, Inc. Raises Annual Dividend to $0.87 Per Share ROANOKE, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of RGC Resources, Inc. (Nasdaq: RGCO), at its meeting on November 24, 2025, declared a quarterly dividend of $0.2175 per share on the Company’s common stock. The indicated annual dividend is $0.87 per share, a $0.04, or 4.8% per share increase over the prior annual level. The Company has now increased the annual dividend 22 consecutive years. Paul Nester, CEO of RGC Resources, Inc., stated, “The Board’s decision to increase the annual dividend rate reflects ...

 PRESS RELEASE

RGC Resources, Inc. Schedules Fourth Quarter 2025 Earnings Call

RGC Resources, Inc. Schedules Fourth Quarter 2025 Earnings Call ROANOKE, Va., Nov. 20, 2025 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal fourth quarter 2025 on Thursday, December 4, 2025 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at .Interested parties may access the conference call by dialing toll-free 1-877-304-9269 and entering conference identification number 917621. An arc...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch